帝人：耗材Alvesco（克索奈德）：厚生劳动省/用于临床研究
2020年3月10日
帝人药业：Alvesco（ciclesonide）
3月9日，帝人药业收到了厚生劳动省的结核病供应请求。
厚生劳动省将其视为治疗冠状病毒的新疗法。
帝人药业已获得生产和销售许可，可用于吸入类固醇哮喘治疗（通用名称：ciclesonide）。
新闻|帝人有限公司
https://www.teijin.co.jp/news/2020/20200310_2538.html
Japan Govt Orders 20,000 Alvesco Inhalers as Coronavirus Measure
Teijin Pharma will supply 20,000 bottles of its inhaled corticosteroid Alvesco (ciclesonide)
to the Japanese government as part of measures against the spread of the novel coronavirus after reports on the drug’s potential as a COVID-19 treatment.
The company said…PHARMA JAPAN
https://pj.jiho.jp/article/241680
Alvesco Inhibits RNA Replications: NIID | PHARMA JAPAN